# Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

> **NCT00026429** · PHASE2 · UNKNOWN · sponsor: **Pharmatech Oncology**

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **BIOLOGICAL:** denileukin diftitox

## Key facts

- **NCT ID:** NCT00026429
- **Lead sponsor:** Pharmatech Oncology
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00026429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00026429, "Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00026429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*